Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00559013 · ClinicalTrials.gov registry record · NA
Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery
A NA study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00559013 is a NA study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 38 participants.
The verdict
NCT00559013, a NA study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Purpose of the study is to assess the utility of PSD Veritas as a staple line reinforcement to minimize the risk of leakage during or after colo-rectal surgery.
Interventions
- DEVICE Staple line reinforcement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00559013
The ClinicalTrials.gov registry entry for NCT00559013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Staple line reinforcement is the first listed.
NCT00559013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00559013 about?
NCT00559013 is a clinical study titled "Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery". Purpose of the study is to assess the utility of PSD Veritas as a staple line reinforcement to minimize the risk of leakage during or after colo-rectal surgery.
What is the current status of trial NCT00559013?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2007-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00559013?
The interventions under investigation include: Staple line reinforcement (DEVICE).
Who is sponsoring clinical trial NCT00559013?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.